Feed / Theme
Confirmed

Healthcare Innovators

17 names are moving together; 65% are participating in the current session.

3 observed Confirmed episodes

Co-movement

Observed member paths adjusted against SPY. Shading marks the latest observation window.

Members

TICKERCompanySectorTodayObserved activity
CHAICore AI Holdings, Inc.Communication Services-10.9%Group member
SENSSenseonics Holdings, Inc.Healthcare-1.9%Group member
ADPTAdaptive Biotechnologies CorporHealthcare-0.3%Group member
LOMALoma Negra Compania IndustrialBasic Materials-3.0%Group member
FIVEFive Below, Inc.Consumer Cyclical+1.2%Group member
NVSTEnvista Holdings CorporationHealthcare+1.2%Group member
VCYTVeracyte, Inc.Healthcare+0.9%2/12 observed active sessions
BURBurford Capital LimitedFinancial Services+0.4%1/12 observed active sessions
TDUPThredUp Inc.Consumer Cyclical-6.1%2/12 observed active sessions
PSNLPersonalis, Inc.Healthcare+7.0%1/12 observed active sessions
CORTCorcept Therapeutics IncorporatHealthcare-6.4%2/12 observed active sessions
ALHAlliance Laundry Holdings Inc.Consumer Cyclical-1.3%Group member
ITRIItron, Inc.Technology-1.9%3/12 observed active sessions
OSISOSI Systems, Inc.Technology-1.7%Group member
SPHRSphere Entertainment Co.Communication Services-2.3%1/12 observed active sessions
TXG10x Genomics, Inc.Healthcare-1.9%1/12 observed active sessions
TWSTTwist Bioscience CorporationHealthcare-0.3%Group member

Why we believe this

Cohort

17 names

Participation

65% this session

Observed history

19 daily builds

Filing coverage

15/17 members

credit / rates affecting interest expense

Interest Expense Three Months Ended March 31, Change (in thousands, except percentages) 2026 2025 $ % Interest expense $ (2,889 ) $ (2,905 ) $ 16 (1)% The nominal decrease in interest expense was attributable to a change in our assumptions regarding the timeframe in which our Purchase Agreement will be fully repaid.

ADPT 10-Q

restructuring

If our operations are found to be in violation of any of such laws or any other governmental regulations that apply to us, we may be subject to penalties, including, without limitation, civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, exclusion from participation in federal and state healthcare programs and imprisonment, any of which could adversely affect our ability to operate our business and our financial results.

CORT 10-K

restructuring affecting expense

ept percentages) 2025 2024 $ % 2025 2024 Impairment of long-lived assets $ — $ 7,205 $ (7,205 ) (100)% 0 % 17 % The $7.2 million decrease in impairment of long-lived assets expenses was attributable to the impairment of certain long-lived assets and our decision to vacate certain leased space as a result of various restructuring activities in 2024.

ADPT 10-Q

This identity theme becomes less useful if activity narrows to one or two names instead of remaining broad across the cohort.

Connected, outside the group

NTRA

PSNLcustomer · Not moving with the group now

Filing receipt · NTRA / PSNL

First Quarter 2026 Highlights Total revenue of $15.5 million decreased 25%, or $5.1 million, during the first quarter of 2026 compared to the first quarter of 2025, due…

PSNL · customer
MRNA

PSNLcustomer · Not moving with the group now

Filing receipt · MRNA / PSNL

For example, we are providing genomic testing services to ModernaTX, Inc.

PSNL · customer
CAI

PSNLcompetitor · Not moving with the group now

Filing receipt · CAI / PSNL

Our competitors in blood-based molecular profiling for MRD tracking and treatment monitoring include Natera, Guardant Health, SAGA Diagnostics, Personalis, BillionToOne,…

PSNL · competitor
ILMN

PSNLsupplier · Not moving with the group now

Filing receipt · ILMN / PSNL

For example, we rely on Illumina as our sole supplier of sequencers and various associated reagents and other materials used in our routine laboratory operations, and as…

PSNL · supplier
MRK

PSNLinvestee · Not moving with the group now

Filing receipt · MRK / PSNL

Pursuant to the terms of the Merck Investment Agreement, the Company agreed to reserve $ 10.0 million of the proceeds to open an ISO-certified laboratory in a region out…

PSNL · investee

History

2026-07-07 → 2026-07-134 observed active sessions · 0% of active names held across the episode
2026-06-24 → 2026-07-027 observed active sessions · 5.9% of active names held across the episode
2026-06-171 observed active session · 100% of active names held across the episode